Data443 Risk Mitigation Inc (ATDS)

[Bubae]

Second post about Omkharan Arasaratnam. There were a couple of payments to advisory board members in February. In shares of course. I'm sure you remember the big deal that was made about this guy summer of 2020 only to never hear is name again.


Board members for sure with people who can bring credibility to the story. I posted a couple of days ago about Omkharan Arasaratnam. I'm sure you remember that this name caused some buzz last summer when it was released. This person would be a strong candidate and already has a relationship with the company. There are two payments listed for February 3rd to consultants so it appears that he likely is still be on board. Those payments should have converted for $40K plus easily at that time.

Maxim will also profit nicely from an uplist. There is a lot of potential catalysts coming if the NASDAQ narrative is real. One would be announcing a different corporate governance structure to replace Jason's controlling interest. I have my doubts given the history.

https://sec.report/Document/0001493152-21-006652/

"On February 03, 2021, the Company issued 1,250,000 shares of its common stock to a member of the Company’s Advisory Board. The issuance was exempt under Section 4(a)(2) of the Securities Act."

"On February 03, 2021, the Company issued 1,250,000 shares of its common stock to a member of the Company’s Advisory Board. The issuance was exempt under Section 4(a)(2) of the Securities Act."


Maxim Agreement

https://sec.report/Document/0001493152-20-017237/

https://www.otcmarkets.com/stock/ATDSD/news/Data443-Risk-Mitigation-Inc-Engages-Maxim-Group-LLC-to-Assist-with-its-Growth-Strategy-and-Goal-to-Up-list-to-a-National?id=272681

DATA443 RISK MITIGATION WELCOMES MR. OMKHAR ARASARATNAM TO ITS ADVISORY BOARD
https://www.otcmarkets.com/stock/ATDSD/news/DATA443-RISK-MITIGATION-WELCOMES-MR-OMKHAR-ARASARATNAM-TO-ITS-ADVISORY-BOARD?id=269031

https://sec.report/Document/0001493152-20-014876/

“Effective July 28, 2020, the company entered into an Advisory Board Agreement (the “Advisory Agreement”) with Omkharan Arasaratnam (the “Advisor”). Pursuant to the Advisory Agreement, the Advisor joined the Advisory Board of the Company for a term of 12-months, although either party may terminate the Advisory Agreement early upon proper notice. The Company agreed to issue to the Advisor five million (5,000,000) shares of its common stock to the Advisor, which shares shall vest at the rate of 25% every 3-months under the Advisory Agreement. The issuance was exempt under Section 4(a)(2) of the Securities Act.”